
About us

Julie Ann Fan
Senior Program Manager





What people who have worked with me say
It is my distinct pleasure to write this letter of recommendation for JulieAnn Fan. I had the privilege of serving as her direct mentor during her transition from Finance to Program Management. JulieAnn distinguished herself through her unwavering dedication to continuous learning, ambition, and leadership-oriented approach.
As a leader, JulieAnn adeptly adjusts her style to be both entrepreneurial and strategic, effectively setting direction for her team. Her influence has resulted in launch of HemoSphere Alta, Critical Care’s new flagship product, reflecting her passion for innovation and commitment to improving patient outcomes. JulieAnn's foresight allows her to anticipate and address future customer needs, demonstrating her exceptional strategic vision. JulieAnn is a natural leader who excels at building strong partnerships across diverse functions, including R&D, manufacturing, marketing, regulatory, and quality. She possesses a unique ability to understand and respond to the needs of others, making her work a benchmark among her peers. During her tenure at Edwards, JulieAnn consistently excelled, earning the prestigious "High Potential" status, an honor reserved for the top 10% of employees. She achieved this distinction due to her critical and pragmatic thinking, as well as her relentless drive to produce exemplary work. JulieAnn's remarkable contributions have led to three promotions, underscoring her ability to navigate and overcome complex challenges.
From the moment I began working with JulieAnn, it was evident that she possessed the potential to surpass the opportunities at Edwards and achieve even greater accomplishments. JulieAnn is one of the most intelligent, driven, and passionate individuals I have had the pleasure of knowing. Her ambition and vision will undoubtedly result in far-reaching positive impacts.
For these reasons, I highly recommend JulieAnn Fan for any strategic and leadership role within your organization. Her collaborative spirit and exceptional talent will undoubtedly make her a valuable asset, contributing to the successful delivery of outstanding products. I am confident that she will exceed your expectations.
Marc Comtois
Principal Consultant at Agile Medical Device Consulting LLC

HemoSphere Stream™
Received 510(k) clearance in 30 days
Latest generation of clinically proven technology designed to help clinicals detect hypotension and related risk
Scalable solution that easily integrates and is compatible with standard bedside monitors, expanding care to a broader population
Successfully directed a cross-functional team of 70 dedicated employees (software, mechanical, hardware, and systems teams) and managed three parallel cable projects handled by separate program managers
Transition HS Stream as the first program through the new PDP process
Took ownership of design verification and validation issues, resolving concerns such as Intertek Canada Label non-compliance
Effectively resolved challenges, including overseeing ~100 software bug fixes, addressing manufacturing issues, showcasing adaptability and problem-solving skills
HemoSphere Alta™
Received 510(k) clearance in 30 days
2nd pump for Clear Sight Module for continuous dual cuff blood pressure monitoring
Target Market Release in February 2024
Will begin to replace HemoSphere starting in 2025
Successfully directed a cross-functional team of 70 dedicated employees (software, mechanical, hardware, and systems teams) and managed three parallel cable projects handled by separate program managers.
Effectively resolved challenges, including overseeing 130 software bug fixes, addressing backplane reset issues, and resolving HDMI screen instability, showcasing adaptability and problem-solving skills.
Proactively managed scope and budget changes for HemoSphere Alta, ensuring alignment with leadership and organizational objectives.
Took ownership of design verification and validation issues, resolving concerns such as Intertek Canada Label non-compliance.
Managed Phase 2 through 4 Phase Closures, demonstrating a commitment to project success.
Successfully managed the program budget of $8 million in 2023 and $6 million in 2022 (excluding headcount expenses) for HemoSphere
Alta Achieved product list price targets ranging between $50,000 - $65,000. Project sales in 2026 ~4,000 units or ~$200M.
HemoSphere Alta 2
This program was primarily an algorithms integration & implementation program with GUI software enhancements. No mechanical or hardware changes occurred.
5 new algorithms (RVCO, Volume View, Smart Wedge, CAI, tHB)
This program integrated 3 new cables (AFM, PSC2 & Swan IQ) and 1 additional sensor (ForeSight IQ cuff)
Translation of 27 languages
New cables (AFM & PSC2 & Swan IQ)
1 sensor rebrand (Foresight IQ)
Paperless Journal Entry Project
Stakeholder management
Management of IT resources & budget


Ready to bring your unique vision to life?















